デフォルト表紙
市場調査レポート
商品コード
1760572

インターベンショナル肺ソリューションの世界市場レポート 2025年

Interventional Lung Solutions Global Market Report 2025


出版日
ページ情報
英文 175 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.09円
インターベンショナル肺ソリューションの世界市場レポート 2025年
出版日: 2025年07月01日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

インターベンショナル肺ソリューション市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.3%で34億3,000万米ドルに成長します。予測期間の成長は、遠隔医療と遠隔モニタリングの採用拡大、個別化医療への注目の高まり、ロボット支援手術の人気上昇、低侵襲手術の採用拡大、精密医療への注目の高まりに起因すると考えられます。この期間に予想される主な動向には、高度な肺がん介入の開発、気管支鏡システムにおける人工知能の統合、インターベンショナル呼吸器学と腫瘍学治療の融合、肺疾患管理のためのデジタルプラットフォームの統合、肺再生治療におけるイノベーションなどがあります。

呼吸器疾患の有病率の増加は、今後数年間のインターベンショナル肺ソリューション市場の拡大を大きく促進すると予想されます。呼吸器疾患は、肺や気道に影響を及ぼし、呼吸を損ない、正常な呼吸機能を阻害するさまざまな病状を包含します。呼吸器疾患の増加は、有害な空気中の粒子や刺激物に長時間さらされる大気汚染レベルの上昇に大きく起因しています。インターベンショナル肺ソリューションは、慢性肺疾患患者の肺機能を改善し、症状を緩和する低侵襲性手技を提供することで、これらの疾患の管理を支援します。例えば、2023年11月、米国の政府機関である疾病対策予防センター(CDC)は、2022年の米国における結核患者数を約8,331人と報告し、前年比5.9%増を記録しました。このような呼吸器疾患の有病率の増加が、インターベンショナル肺ソリューション市場の成長を牽引しています。

インターベンショナル肺ソリューション市場の主なプレーヤーは、肺がん診断の精度を高め、低侵襲手技を可能にし、高度なナビゲーションと生検機能によって患者の転帰を改善するために、Ion Endoluminal Systemなどの最先端技術の開発に注力しています。Ion Endoluminal Systemは、低侵襲肺手技のために設計されたロボット支援プラットフォームであり、小さな肺結節や到達困難な肺結節にアクセスするための正確な気道ナビゲーションを可能にします。例えば、2024年4月、米国の非営利団体であるH.リー・モフィットがんセンター・調査研究所財団(H.Lee Moffitt Cancer Center and Research Institute Foundation Inc.)は、先進的な光ファイバー技術と低侵襲カテーテルシステムによるインターベンショナル・パルモノロジー・プログラムを強化するため、新しいイオンロボット気管支鏡プラットフォームを立ち上げました。この技術は、光ファイバーと市場で入手可能な最小のカテーテルを採用し、肺の全領域にアクセスします。このシステムは、180°の関節、統合されたリアルタイム・ビジョン、および形状感知技術を備えた、極細で操作性の高いカテーテルを特徴としており、到達が困難な末梢肺結節の正確なナビゲーションと生検を可能にします。このシステムは、組織採取においてかつてない安定性と精度を提供し、医師が18の肺分節すべてに到達できるようにすることで、早期肺がんの発見を向上させる。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場:金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界のインターベンショナル肺ソリューション:PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界のインターベンショナル肺ソリューション市場:成長率分析
  • 世界のインターベンショナル肺ソリューション市場の実績:規模と成長、2019年~2024年
  • 世界のインターベンショナル肺ソリューション市場の予測:規模と成長、2024年~2029年、2034年
  • 世界のインターベンショナル肺ソリューション:総潜在市場規模(TAM)

第6章 市場セグメンテーション

  • 世界のインターベンショナル肺ソリューション市場:製品タイプ別、実績と予測、2019年~2024年、2024年~2029年、2034年
  • 気管支鏡
  • 気管支内超音波針
  • 胸腔鏡
  • 気道ステント
  • その他の製品タイプ
  • 世界のインターベンショナル肺ソリューション市場:技術別、実績と予測、2019年~2024年、2024年~2029年、2034年
  • ロボット手術
  • レーザー療法
  • 電磁ナビゲーション気管支鏡検査
  • 世界のインターベンショナル肺ソリューション市場:処置別、実績と予測、2019年~2024年、2024年~2029年、2034年
  • 気管支鏡検査
  • 胸腔鏡検査
  • 胸膜鏡検査
  • その他の処置
  • 世界のインターベンショナル肺ソリューション市場:用途別、実績と予測、2019年~2024年、2024年~2029年、2034年
  • 肺がんの治療
  • 慢性閉塞性肺疾患
  • 睡眠時無呼吸症候群の治療
  • 世界のインターベンショナル肺ソリューション市場:エンドユーザー別、実績と予測、2019年~2024年、2024年~2029年、2034年
  • 病院
  • 外来手術センター
  • 専門クリニック
  • その他のエンドユーザー
  • 世界のインターベンショナル肺ソリューション市場、気管支鏡の種類別サブセグメンテーション、実績と予測、2019年~2024年、2024年~2029年、2034年
  • フレキシブル気管支鏡
  • 硬性気管支鏡
  • 使い捨て気管支鏡
  • 世界のインターベンショナル肺ソリューション市場、気管支内超音波針の種類別サブセグメンテーション、実績と予測、2019年~2024年、2024年~2029年、2034年
  • 経気管支吸引針
  • 生検針
  • 世界のインターベンショナル肺ソリューション市場、胸腔鏡の種類別のサブセグメンテーション、実績と予測、2019年~2024年、2024年~2029年、2034年
  • フレキシブル胸腔鏡
  • 半硬性胸腔鏡
  • 世界のインターベンショナル肺ソリューション市場、気道ステントの種類別サブセグメンテーション、実績と予測、2019年~2024年、2024年~2029年、2034年
  • 金属ステント
  • シリコンステント
  • ハイブリッドステント
  • 世界のインターベンショナル肺ソリューション市場、その他の製品タイプのサブセグメンテーション、タイプ別、実績と予測、2019年~2024年、2024年~2029年、2034年
  • 気管支熱形成術用デバイス
  • 肺容量減少装置
  • 電磁航行システム
  • 凍結療法およびアブレーション装置

第7章 地域別・国別分析

  • 世界のインターベンショナル肺ソリューション市場:地域別、実績と予測、2019年~2024年、2024年~2029年、2034年
  • 世界のインターベンショナル肺ソリューション市場:国別、実績と予測、2019年~2024年、2024年~2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • インターベンショナル肺ソリューション市場:競合情勢
  • インターベンショナル肺ソリューション市場:企業プロファイル
    • Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Siemens AG Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • FUJIFILM Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Boston Scientific Corporation
  • Olympus Corporation
  • Intuitive Surgical Inc.
  • Smiths Medical Inc.
  • Cook Medical Inc.
  • Merit Medical Systems Inc.
  • Penumbra Inc.
  • Vygon SA
  • AngioDynamics Inc.
  • Vapotherm Inc.
  • Pulmonx Corporation
  • Broncus Medical Inc.
  • Thirona B.V.
  • Body Vision Medical Ltd.
  • The Lung Docs Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • インターベンショナル肺ソリューション市場2029年:新たな機会を提供する国
  • インターベンショナル肺ソリューション市場2029年:新たな機会を提供するセグメント
  • インターベンショナル肺ソリューション市場2029年:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r35449

Interventional lung solutions refer to minimally invasive procedures and technologies designed to diagnose and treat lung conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, and emphysema. These solutions typically include interventions such as bronchoscopy, endobronchial valves, and image-guided therapies, all aimed at improving lung function and enhancing patient outcomes.

The main types of interventional lung solutions include bronchoscopes, endobronchial ultrasound needles, pleuroscopes, airway stents, and other related devices. Bronchoscopes are medical instruments used to visualize and examine the airways and lungs, typically inserted through the nose or mouth to diagnose and treat respiratory conditions. Technologies associated with bronchoscopes include robotic surgery, laser therapy, and electromagnetic navigation bronchoscopy. The procedures involved include bronchoscopy, thoracoscopy, pleuroscopy, and others. These solutions are applied in various medical fields such as lung cancer treatment, COPD management, and sleep apnea treatment, and are used by a variety of end-users, including hospitals, ambulatory surgical centers, specialty clinics, and other healthcare settings.

The interventional lung solutions market research report is one of a series of new reports from The Business Research Company that provides interventional lung solutions market statistics, including the interventional lung solutions industry's global market size, regional shares, competitors with the interventional lung solutions market share, detailed interventional lung solutions market segments, market trends and opportunities, and any further data you may need to thrive in the interventional lung solutions market. This interventional lung solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The interventional lung solutions market size has grown strongly in recent years. It will grow from $2.30 billion in 2024 to $2.49 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth during the historic period can be attributed to the increasing prevalence of respiratory diseases, the growing number of smokers worldwide, rising air pollution levels, increasing healthcare awareness, and the growing number of lung cancer cases.

The interventional lung solutions market size is expected to see strong growth in the next few years. It will grow to $3.43 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to the growing adoption of telemedicine and remote monitoring, an increasing focus on personalized medicine, the rising popularity of robotic-assisted surgery, the growing adoption of minimally invasive procedures, and an increasing focus on precision medicine. Major trends expected during this period include the development of advanced lung cancer interventions, the integration of artificial intelligence in bronchoscopy systems, the merging of interventional pulmonology with oncology treatments, the integration of digital platforms for lung disease management, and innovations in lung regeneration therapies.

The growing prevalence of respiratory diseases is expected to significantly drive the expansion of the interventional lung solutions market in the coming years. Respiratory diseases encompass a range of medical conditions that affect the lungs and airways, impairing breathing and disrupting normal respiratory function. The increase in respiratory diseases is largely attributed to rising levels of air pollution, which contribute to prolonged exposure to harmful airborne particles and irritants. Interventional lung solutions assist in managing these diseases by providing minimally invasive procedures that improve lung function and alleviate symptoms in patients with chronic pulmonary conditions. For example, in November 2023, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported approximately 8,331 tuberculosis cases in the United States in 2022, marking a 5.9% increase from the previous year. This growing prevalence of respiratory diseases is driving the growth of the interventional lung solutions market.

Key players in the interventional lung solutions market are focusing on the development of cutting-edge technologies, such as the Ion Endoluminal System, to enhance the accuracy of lung cancer diagnostics, enable minimally invasive procedures, and improve patient outcomes through advanced navigation and biopsy capabilities. The Ion Endoluminal System is a robotic-assisted platform designed for minimally invasive lung procedures, enabling precise airway navigation to access small or difficult-to-reach lung nodules. For example, in April 2024, the H. Lee Moffitt Cancer Center and Research Institute Foundation Inc., a US-based non-profit organization, launched a new Ion Robotic Bronchoscopy platform to enhance their interventional pulmonology program with advanced fiber-optic technology and a minimally invasive catheter system. This technology employs fiber optics and the smallest catheter available on the market to access all areas of the lungs. It features an ultra-thin, highly maneuverable catheter with 180° articulation, integrated real-time vision, and shape-sensing technology, enabling precise navigation and biopsy of peripheral lung nodules that are difficult to reach. This system offers unprecedented stability and accuracy for tissue sampling, enabling physicians to reach all 18 lung segments, thus improving the detection of early-stage lung cancer.

In February 2025, Stryker Corporation, a US-based medical device company, acquired Inari Medical Inc. for an undisclosed amount. This acquisition is aimed at strengthening Stryker's interventional endovascular portfolio by adding innovative thrombolytic-free solutions for treating venous thromboembolism (VTE), including pulmonary embolism and deep vein thrombosis. Inari Medical Inc., based in the US, specializes in providing interventional solutions for pulmonary conditions, with a particular focus on treating pulmonary embolism (PE).

Major players in the interventional lung solutions market are Johnson and Johnson, Siemens AG, Medtronic plc, FUJIFILM Holdings Corporation, GE Healthcare Technologies Inc., Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc., Smiths Medical Inc., Cook Medical Inc., Merit Medical Systems Inc., Penumbra Inc., Vygon SA, AngioDynamics Inc., Vapotherm Inc., Pulmonx Corporation, Broncus Medical Inc., Thirona B.V., Body Vision Medical Ltd., The Lung Docs Inc., EndoMed Systems GmbH.

North America was the largest region in the interventional lung solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in interventional lung solutions report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the interventional lung solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The interventional lung solutions market consists of revenues earned by entities by providing services such as endobronchial valve placement, navigational bronchoscopy, lung volume reduction, and airway stenting. The market value includes the value of related goods sold by the service provider or included within the service offering. The interventional lung solutions market also consists of sales of products including bronchial thermoplasty devices, cryotherapy devices, bronchial stents, and biopsy forceps. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Interventional Lung Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on interventional lung solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for interventional lung solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The interventional lung solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Bronchoscopes; Endobronchial Ultrasound Needles; Pleuroscopes; Airway Stents; Other Product Types
  • 2) By Technology: Robotic Surgery; Laser Therapy; Electromagnetic Navigation Bronchoscopy
  • 3) By Procedure: Bronchoscopy; Thoracoscopy; Pleuroscopy; Other Procedures
  • 4) By Application: Lung Cancer Treatment; Chronic Obstructive Pulmonary Disease; Sleep Apnea Treatment
  • 5) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End-Users
  • Subsegments:
  • 1) BY Bronchoscopes: Flexible Bronchoscopes; Rigid Bronchoscopes; Disposable Bronchoscopes
  • 2) By Endobronchial Ultrasound Needles: Transbronchial Aspiration Needles; Biopsy Needles
  • 3) By Pleuroscopes: Flexible Pleuroscopes; Semi-Rigid Pleuroscopes
  • 4) By Airway Stents: Metallic Stents; Silicone Stents; Hybrid Stents
  • 5) By Other Product Types: Bronchial Thermoplasty Devices; Lung Volume Reduction Devices; Electromagnetic Navigation Systems; Cryotherapy And Ablation Devices
  • Companies Mentioned: Johnson and Johnson; Siemens AG; Medtronic plc; FUJIFILM Holdings Corporation; GE Healthcare Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Interventional Lung Solutions Market Characteristics

3. Interventional Lung Solutions Market Trends And Strategies

4. Interventional Lung Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Interventional Lung Solutions Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Interventional Lung Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Interventional Lung Solutions Market Growth Rate Analysis
  • 5.4. Global Interventional Lung Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Interventional Lung Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Interventional Lung Solutions Total Addressable Market (TAM)

6. Interventional Lung Solutions Market Segmentation

  • 6.1. Global Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bronchoscopes
  • Endobronchial Ultrasound Needles
  • Pleuroscopes
  • Airway Stents
  • Other Product Types
  • 6.2. Global Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Robotic Surgery
  • Laser Therapy
  • Electromagnetic Navigation Bronchoscopy
  • 6.3. Global Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bronchoscopy
  • Thoracoscopy
  • Pleuroscopy
  • Other Procedures
  • 6.4. Global Interventional Lung Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lung Cancer Treatment
  • Chronic Obstructive Pulmonary Disease
  • Sleep Apnea Treatment
  • 6.5. Global Interventional Lung Solutions Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Other End-Users
  • 6.6. Global Interventional Lung Solutions Market, Sub-Segmentation Of Bronchoscopes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Flexible Bronchoscopes
  • Rigid Bronchoscopes
  • Disposable Bronchoscopes
  • 6.7. Global Interventional Lung Solutions Market, Sub-Segmentation Of Endobronchial Ultrasound Needles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transbronchial Aspiration Needles
  • Biopsy Needles
  • 6.8. Global Interventional Lung Solutions Market, Sub-Segmentation Of Pleuroscopes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Flexible Pleuroscopes
  • Semi-Rigid Pleuroscopes
  • 6.9. Global Interventional Lung Solutions Market, Sub-Segmentation Of Airway Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metallic Stents
  • Silicone Stents
  • Hybrid Stents
  • 6.10. Global Interventional Lung Solutions Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bronchial Thermoplasty Devices
  • Lung Volume Reduction Devices
  • Electromagnetic Navigation Systems
  • Cryotherapy And Ablation Devices

7. Interventional Lung Solutions Market Regional And Country Analysis

  • 7.1. Global Interventional Lung Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Interventional Lung Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Interventional Lung Solutions Market

  • 8.1. Asia-Pacific Interventional Lung Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Interventional Lung Solutions Market

  • 9.1. China Interventional Lung Solutions Market Overview
  • 9.2. China Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Interventional Lung Solutions Market

  • 10.1. India Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Interventional Lung Solutions Market

  • 11.1. Japan Interventional Lung Solutions Market Overview
  • 11.2. Japan Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Interventional Lung Solutions Market

  • 12.1. Australia Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Interventional Lung Solutions Market

  • 13.1. Indonesia Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Interventional Lung Solutions Market

  • 14.1. South Korea Interventional Lung Solutions Market Overview
  • 14.2. South Korea Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Interventional Lung Solutions Market

  • 15.1. Western Europe Interventional Lung Solutions Market Overview
  • 15.2. Western Europe Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Interventional Lung Solutions Market

  • 16.1. UK Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Interventional Lung Solutions Market

  • 17.1. Germany Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Interventional Lung Solutions Market

  • 18.1. France Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Interventional Lung Solutions Market

  • 19.1. Italy Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Interventional Lung Solutions Market

  • 20.1. Spain Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Interventional Lung Solutions Market

  • 21.1. Eastern Europe Interventional Lung Solutions Market Overview
  • 21.2. Eastern Europe Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Interventional Lung Solutions Market

  • 22.1. Russia Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Interventional Lung Solutions Market

  • 23.1. North America Interventional Lung Solutions Market Overview
  • 23.2. North America Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Interventional Lung Solutions Market

  • 24.1. USA Interventional Lung Solutions Market Overview
  • 24.2. USA Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Interventional Lung Solutions Market

  • 25.1. Canada Interventional Lung Solutions Market Overview
  • 25.2. Canada Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Interventional Lung Solutions Market

  • 26.1. South America Interventional Lung Solutions Market Overview
  • 26.2. South America Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Interventional Lung Solutions Market

  • 27.1. Brazil Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Interventional Lung Solutions Market

  • 28.1. Middle East Interventional Lung Solutions Market Overview
  • 28.2. Middle East Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Interventional Lung Solutions Market

  • 29.1. Africa Interventional Lung Solutions Market Overview
  • 29.2. Africa Interventional Lung Solutions Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Interventional Lung Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Interventional Lung Solutions Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Interventional Lung Solutions Market Competitive Landscape And Company Profiles

  • 30.1. Interventional Lung Solutions Market Competitive Landscape
  • 30.2. Interventional Lung Solutions Market Company Profiles
    • 30.2.1. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. FUJIFILM Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Interventional Lung Solutions Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. Olympus Corporation
  • 31.3. Intuitive Surgical Inc.
  • 31.4. Smiths Medical Inc.
  • 31.5. Cook Medical Inc.
  • 31.6. Merit Medical Systems Inc.
  • 31.7. Penumbra Inc.
  • 31.8. Vygon SA
  • 31.9. AngioDynamics Inc.
  • 31.10. Vapotherm Inc.
  • 31.11. Pulmonx Corporation
  • 31.12. Broncus Medical Inc.
  • 31.13. Thirona B.V.
  • 31.14. Body Vision Medical Ltd.
  • 31.15. The Lung Docs Inc.

32. Global Interventional Lung Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Interventional Lung Solutions Market

34. Recent Developments In The Interventional Lung Solutions Market

35. Interventional Lung Solutions Market High Potential Countries, Segments and Strategies

  • 35.1 Interventional Lung Solutions Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Interventional Lung Solutions Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Interventional Lung Solutions Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer